FI104949B - Menetelmä säädellysti budesonidia vapauttavan oraalisesti annettavan koostumuksen valmistamiseksi - Google Patents

Menetelmä säädellysti budesonidia vapauttavan oraalisesti annettavan koostumuksen valmistamiseksi Download PDF

Info

Publication number
FI104949B
FI104949B FI922325A FI922325A FI104949B FI 104949 B FI104949 B FI 104949B FI 922325 A FI922325 A FI 922325A FI 922325 A FI922325 A FI 922325A FI 104949 B FI104949 B FI 104949B
Authority
FI
Finland
Prior art keywords
budesonide
epimer
water
hours
polymer
Prior art date
Application number
FI922325A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI922325A0 (fi
FI922325A (fi
Inventor
Jan Ulmius
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20377544&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI104949(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Draco Ab filed Critical Draco Ab
Publication of FI922325A0 publication Critical patent/FI922325A0/fi
Publication of FI922325A publication Critical patent/FI922325A/fi
Application granted granted Critical
Publication of FI104949B publication Critical patent/FI104949B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
FI922325A 1989-11-22 1992-05-21 Menetelmä säädellysti budesonidia vapauttavan oraalisesti annettavan koostumuksen valmistamiseksi FI104949B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE8903914A SE8903914D0 (sv) 1989-11-22 1989-11-22 Oral composition for the treatment of inflammatory bowel diseases
SE8903914 1989-11-22
SE9000738 1990-11-15
PCT/SE1990/000738 WO1991007172A1 (en) 1989-11-22 1990-11-15 Oral composition for the treatment of inflammatory bowel diseases

Publications (3)

Publication Number Publication Date
FI922325A0 FI922325A0 (fi) 1992-05-21
FI922325A FI922325A (fi) 1992-05-21
FI104949B true FI104949B (fi) 2000-05-15

Family

ID=20377544

Family Applications (2)

Application Number Title Priority Date Filing Date
FI922325A FI104949B (fi) 1989-11-22 1992-05-21 Menetelmä säädellysti budesonidia vapauttavan oraalisesti annettavan koostumuksen valmistamiseksi
FI991893A FI19991893A (fi) 1989-11-22 1999-09-06 Säädellysti budesonidia vapauttava oraalisesti annettava koostumus ja budesonidin käyttö

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI991893A FI19991893A (fi) 1989-11-22 1999-09-06 Säädellysti budesonidia vapauttava oraalisesti annettava koostumus ja budesonidin käyttö

Country Status (36)

Country Link
US (1) US6423340B1 (xx)
EP (1) EP0502092B1 (xx)
JP (1) JP3145111B2 (xx)
KR (1) KR0179042B1 (xx)
AT (1) ATE125445T1 (xx)
AU (1) AU643021B2 (xx)
CA (1) CA2071518C (xx)
DE (1) DE69021214T2 (xx)
DK (1) DK0502092T3 (xx)
EG (1) EG19642A (xx)
ES (1) ES2074698T3 (xx)
FI (2) FI104949B (xx)
GR (1) GR3017691T3 (xx)
HK (1) HK51897A (xx)
HR (1) HRP920632B1 (xx)
HU (2) HU216836B (xx)
IE (1) IE74854B1 (xx)
IL (1) IL96415A (xx)
IS (1) IS1858B (xx)
LT (1) LT3696B (xx)
LV (1) LV10183B (xx)
MY (1) MY104535A (xx)
NO (1) NO304010B1 (xx)
NZ (1) NZ235807A (xx)
PL (1) PL166506B1 (xx)
PT (1) PT95946A (xx)
RU (1) RU2134104C1 (xx)
SA (1) SA90110123B1 (xx)
SE (1) SE8903914D0 (xx)
SG (1) SG54210A1 (xx)
SI (1) SI9012150A (xx)
TW (1) TW250435B (xx)
UA (1) UA37196C2 (xx)
WO (1) WO1991007172A1 (xx)
YU (1) YU48583B (xx)
ZA (1) ZA908777B (xx)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5316772A (en) * 1990-12-19 1994-05-31 Solvay & Cie, S.A. (Societe Anonyme) Bilayered oral pharmaceutical composition with pH dependent release
JP3366640B2 (ja) * 1993-01-08 2003-01-14 アストラ・アクチエボラーグ 新規な結腸−または回腸−特異的ステロイド誘導体
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
DE4332394A1 (de) * 1993-09-23 1995-03-30 Falk Pharma Gmbh Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
AU739031B2 (en) * 1996-11-15 2001-10-04 Procter & Gamble Company, The Pharmaceutical dosage form for colonic delivery
SE9604751D0 (sv) 1996-12-20 1996-12-20 Astra Ab New therapy
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US6239120B1 (en) 1998-03-17 2001-05-29 Pharmalink Ab Method and means for treating glomerulonephritis
GB9824604D0 (en) 1998-11-11 1999-01-06 Hewlett Healthcare Limited Treatment of allergic conditions
SE9902673D0 (sv) * 1999-07-12 1999-07-12 Astra Ab New composition
DE60237363D1 (de) * 2001-03-15 2010-09-30 Soligenix Inc Verfahren zur behandlung von entzündlichen erkrankungen des verdauungstrakts mit topisch wirksamen kortikosteroiden
DE10250543A1 (de) * 2002-10-29 2004-05-19 Röhm GmbH & Co. KG Mehrschichtige Arzneiform
ES2312844T3 (es) 2002-12-12 2009-03-01 Nycomed Gmbh Medicamento de combinacion de r, r-formoterol y ciclesonida.
US20060188563A1 (en) * 2003-03-27 2006-08-24 Hisamitsu Pharmaceutical Co., Inc. Medicinal oral preparations for colon delivery, medicinal oral preparations for treating colon cancer and medicinal oral preparations for treating colitis
US20060211668A1 (en) * 2003-09-15 2006-09-21 Altana Pharma Ag Use of ciclesonide for the treatment of inflammatory bowel diseases
ES2452691T5 (es) 2003-09-16 2022-09-14 Covis Pharma Gmbh Uso de ciclesonida para el tratamiento de enfermedades respiratorias
AU2005264864B2 (en) 2004-06-16 2011-08-11 Takeda Pharmaceutical Company Limited Multiple PPI dosage form
US20070243184A1 (en) * 2005-11-08 2007-10-18 Steven Fischkoff Prophylaxis and treatment of enterocolitis associated with anti-ctla-4 antibody therapy
WO2008117814A1 (ja) * 2007-03-26 2008-10-02 Teikoku Seiyaku Co., Ltd. 大腸送達用経口製剤
GB0808537D0 (en) 2008-05-12 2008-06-18 Archimedes Dev Ltd Compositions
EP2334178A4 (en) * 2008-10-03 2012-04-11 Falk Pharma Gmbh COMPOSITIONS AND METHODS OF TREATING THERAPEUTIC DISEASES WITH GRANULATED MESALAMINE
US8945615B2 (en) * 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
US8945616B2 (en) 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
WO2012106722A2 (en) * 2011-02-04 2012-08-09 Optimer Pharmaceuticals, Inc. Treatment of bacterial infections
MD480Z (en) * 2011-07-07 2012-09-30 Elvira Andon Method for treating acute ulcerative nonspecific colitis
LT2659881T (lt) 2012-04-30 2018-02-12 Tillotts Pharma Ag Uždelsto atpalaidavimo vaisto forma
EP3542791A1 (en) 2013-10-29 2019-09-25 Tillotts Pharma AG A delayed release drug formulation
EP3346996A4 (en) * 2015-09-11 2019-04-17 Sun Pharmaceutical Industries Limited ORAL PHARMACEUTICAL PHARMACEUTICAL FORM OF BUDESONID
CN105663091A (zh) * 2016-01-28 2016-06-15 上海信谊百路达药业有限公司 一种布地奈德肠溶缓释胶囊及其制备方法
RU2750944C2 (ru) * 2016-02-09 2021-07-06 Альбирео Аб Пероральный состав холестирамина и его применение
EP3413878B1 (en) * 2016-02-09 2021-04-14 Albireo AB Oral cholestyramine formulation and use thereof
EP3613414A1 (de) 2018-08-24 2020-02-26 Dr. Falk Pharma Gmbh Pellets mit mehrschichtiger struktur zur verzögerten freisetzung des wirkstoffs im distalen kolon
US11896719B2 (en) 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996356A (en) 1969-07-02 1976-12-07 Hoffmann-La Roche Inc. Composition containing 5-sulfanilamido-3,4-dimethylisoxazole and a trimethoxybenzyl pyrimidine
SE378109B (xx) 1972-05-19 1975-08-18 Bofors Ab
SE7813246L (sv) 1978-12-22 1980-06-23 Haessle Ab Fast farmaceutisk beredning innehallande kroppar med flera ytskikt
FR2471186A1 (fr) 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
SE8003805L (sv) 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
SE8008524L (sv) 1980-12-04 1982-06-05 Draco Ab 4-pregnen-derivat, ett forfarande for deras framstellning, beredning och metod for behandling av inflammatoriska tillstand
ZA825384B (en) 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
SE8306370D0 (sv) 1983-11-18 1983-11-18 Draco Ab Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions
US4708867A (en) 1983-12-19 1987-11-24 Key Pharmaceuticals, Inc. Minipellets
US4606940A (en) 1984-12-21 1986-08-19 The Ohio State University Research Foundation Small particle formation and encapsulation
DE3536267A1 (de) 1985-10-11 1987-04-16 Bayer Ag Azofarbstoffe sowie fluessigkristallines material enthaltend azofarbstoffe
SE8506015D0 (sv) 1985-12-19 1985-12-19 Draco Ab Novel 16,17-acetalsubstituted pregnane 21-oic acid derivatives
GB8630913D0 (en) 1986-12-24 1987-02-04 Glaxo Group Ltd Pharmaceutical compositions
US4966770A (en) 1989-07-26 1990-10-30 Himedics, Inc. Prednisone microencapsulated granules
DE10307386A1 (de) 2003-02-21 2004-09-09 Dieter Wildfang Gmbh Verfahren zum außenseitigen Beschichten eines sanitären Auslaufteiles sowie sanitäres Auslaufteil

Also Published As

Publication number Publication date
HUT60630A (en) 1992-10-28
NO304010B1 (no) 1998-10-12
EG19642A (en) 1995-08-30
YU48583B (sh) 1998-12-23
IS3644A7 (is) 1991-05-23
HK51897A (en) 1997-05-02
AU643021B2 (en) 1993-11-04
IL96415A (en) 1995-11-27
NO922004D0 (no) 1992-05-21
PL166506B1 (pl) 1995-05-31
KR0179042B1 (ko) 1999-03-20
CA2071518A1 (en) 1991-05-23
NZ235807A (en) 1993-02-25
WO1991007172A1 (en) 1991-05-30
ES2074698T3 (es) 1995-09-16
FI922325A0 (fi) 1992-05-21
NO922004L (no) 1992-05-21
HRP920632A2 (en) 1995-04-30
KR920703025A (ko) 1992-12-17
FI922325A (fi) 1992-05-21
IL96415A0 (en) 1991-08-16
SG54210A1 (en) 1998-11-16
EP0502092A1 (en) 1992-09-09
ATE125445T1 (de) 1995-08-15
SA90110123B1 (ar) 1999-06-06
JP3145111B2 (ja) 2001-03-12
DE69021214D1 (de) 1995-08-31
PL287844A1 (en) 1991-12-02
GR3017691T3 (en) 1996-01-31
JPH05501705A (ja) 1993-04-02
PT95946A (pt) 1991-09-13
YU215090A (sr) 1996-01-09
RU2134104C1 (ru) 1999-08-10
FI19991893A (fi) 1999-09-06
LTIP1751A (en) 1995-07-25
DK0502092T3 (da) 1995-12-27
CA2071518C (en) 2002-11-12
EP0502092B1 (en) 1995-07-26
HU216836B (hu) 1999-09-28
IS1858B (is) 2003-03-27
US6423340B1 (en) 2002-07-23
IE904170A1 (en) 1991-05-22
HRP920632B1 (en) 1999-10-31
LV10183A (lv) 1994-10-20
SE8903914D0 (sv) 1989-11-22
TW250435B (xx) 1995-07-01
AU7786491A (en) 1991-06-13
MY104535A (en) 1994-04-30
SI9012150A (sl) 1998-08-31
IE74854B1 (en) 1997-08-13
LV10183B (en) 1995-08-20
ZA908777B (en) 1991-07-31
DE69021214T2 (de) 1996-01-04
LT3696B (en) 1996-02-26
UA37196C2 (uk) 2001-05-15
HU9201700D0 (en) 1992-08-28

Similar Documents

Publication Publication Date Title
FI104949B (fi) Menetelmä säädellysti budesonidia vapauttavan oraalisesti annettavan koostumuksen valmistamiseksi
US5643602A (en) Oral composition for the treatment of inflammatory bowel disease
US5316772A (en) Bilayered oral pharmaceutical composition with pH dependent release
JP4088413B2 (ja) 腸管を処置・治療するペレット製剤
DE60131703T2 (de) Orale feste pharmazeutische Zusammensetzungen mit pH-abhängiger Mehrphasen- Freisetzung
JP2001502333A (ja) 結腸デリバリーのための多腸溶性ポリマーコーティングを有する医薬投薬形態
US20060057200A1 (en) Tablets with site- and time-controlled gastrointestinal release of active ingredient
JPH05506022A (ja) 腸管への薬物放出のための投与形態物
JPH04224517A (ja) 標的制御釈放薬剤
EP1117387A2 (de) Überzogene arzneiformen mit kontrollierter wirkstoffabgabe
KR20090122489A (ko) 결장-특이적 전달을 위한 경구적 약제학적 제제
WO2015018344A1 (zh) 穿心莲内酯在制备炎症性肠病的药物中的应用、穿心莲内酯肠溶靶向微丸及其制备方法
CN107205937A (zh) 包含富马酸二甲酯的药物珠粒制剂
AU2005281797A1 (en) Tablets with site and time-controlled gastrointestinal release of active ingredient
BR112020008128A2 (pt) comprimidos de liberação retardada de deferiprona e métodos para utilização dos mesmos
PL192950B1 (pl) Wielocząstkowa postać farmaceutyczna o opóźnionym i stopniowym uwalnianiu, oraz sposób jej wytwarzania
CN112315934B (zh) 白头翁皂苷b4肠溶片的制备工艺
WO2000048577A1 (de) Arzneimittel zur behandlung bzw. prävention von darmkrebs
CN107224431A (zh) 非布司他改进的释放剂型及其制备方法
CN112494461A (zh) 一种美沙拉嗪肠溶缓释药物组合物及制备方法
EP1100481B1 (en) Pharmaceutical formulations comprising beclomethasone dipropionate for the treatment of inflammatory bowel disease
JP2007505828A (ja) 炎症性腸疾患の治療のためのシクレソニドの使用
CN108778256A (zh) 包含富马酸二甲酯的药物珠粒制剂
EA042135B1 (ru) Таблетка деферипрона с отсроченным высвобождением и способ ее изготовления